A randomized, double-blind, placebo-controlled, pivotal multicenter trial with budesonide orodispersible tablets for treatment of active eosinophilic esophagitis (eos-1) - Lucendo, A J; Miehlke, S; Vieth, M (Digestive Disease Week (DDW), 2017)
(abstract)